DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Bupranolol
Bupranolol
Properties and Units in Clinical Pharmacology and Toxicology
33-Adrenoceptor-Mediated Relaxation Induced by Isoprenaline And
Guidance for the Format and Content of the Protocol of Non-Interventional
Novel Method of Administering Β-Blockers and Novel Dosage Forms Containing Same Anwar A
Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set
An Insight on Analytical Profile on Bisoprolol Fumarate – a Selective Beta-1 Adrenoreceptor Blocker
Drugs for Primary Prevention of Atherosclerotic Cardiovascular Disease: an Overview of Systematic Reviews
Adrenoceptor Agonists on Spontaneous Contractions of Human Nonpregnant Myometrium
Carvedilol Inhibits EGF-Mediated JB6 P+ Colony Formation Through a Mechanism Independent of Adrenoceptors
Pharmacological Properties of Beta-Adrenoceptor Blocking Drugs
A Study on Beta Blockers - a Brief Review Tv
Quality Assurance of Drug Value Sets for Clinical Quality Measures
Review of Existing Classification Efforts
ROSITA Project
The Beta3 Adrenergic Receptor in Healthy and Pathological Cardiovascular Tissues
The Classification of Drugs and Drug Receptors in Isolated Tissues
Adrenoceptor Pharmacology
Index Vol. 16-23
Top View
PET Radiotracers for CNS-Adrenergic Receptors: Developments and Perspectives
Effect of Beta-Blockers on Hypertension and Heart Failure with Reduced Ejection Fraction: a Systematic Review of Randomized Controlled Trials Jeremy G
Of 33 Appendix
ATC-Index Mit DDD-Angaben Für Den Deutschen Arzneimittelmarkt Berlin 2013, 12
NVA237 / Glycopyrronium Bromide Multinational, Multi-Database Cohort
Regis Β Blockers
Β3 -Adrenergic Receptor Activation Increases Human Atrial Tissue
Do Β-Adrenoreceptor Blocking Drugs Associate with Reduced Risk Of
ATC-Index Mit DDD-Angaben Für Deutschland Im Jahre 2019
Evidence Review E: Postnatal Management of Hypertension
(12) United States Patent (10) Patent No.: US 8,414.914 B2 Bromley Et Al
Issue #105-116, 1978
Center for Drug Information and Pharmacy Practice1, ABDA
First-Line Combination Therapy Versus First-Line Monotherapy for Primary Hypertension (Review)
Systemic Delivery of Β-Blockers Via Transdermal Route for Hypertension
Progress in the Enantioseparation of -Blockers by Chromatographic Methods
Molecular and Structural Requirements of the Β1l
Therapeutic and Toxic Blood Concentrations of More Than 1100 Drugs and Other Xenobiotics
APPENDICES Appendix 1
Mesh Terms for 2002
The Korea Food and Drug Administration* Notification 2012-129
Agonist Effects of Propranolol on Non-Tumor Human Breast Cells
[Ehdsi V3.0.0-RC1] Ehealth DSI – Master Value Set Catalogue
Beta-Blocker Use in Pregnancy and Risk of Specific Congenital Anomalies
Structure-Activity Relationship Studies of (±)
Benefits and Harms of Treating Blood Pressure in Older Adults Evidence-Based Synthesis Program APPENDIX A
ICD-10-CM Table of Drugs 2019
Additivit Y to Timolol Twice Daily
Proximal Pathway Enrichment Analysis for Targeting Comorbid Diseases Via Network Endopharmacology
Adrenaline Produces the Relaxation of Guinea-Pig Airway Smooth Muscle Primarily Through the Mediation
Topical Atenolol Versus Pilocarpine: a Double-Blind Study of the Effect on Ocular Tension
Therapeutic and Toxic Blood Concentrations of More Than 800 Drugs and Other Xenobiotics